Publications

The publication of research results is a fundamental requirement for improving treatment concepts across the board. iOMEDICO supports the international guidelines on transparency and publication of medical research results.

We regularly present our data at national and international conferences. Our publications appear in scientifically renowned, international journals. Authors are principal investigators, investigators with a high number of participating patients, and iOMEDICO scientists.

TITEL
STUDIE
JAHR
Ferric Carboxymaltose for the Correction of Cancer- and Chemotherapy-Assiciated Anemia in Clinical Practice.

Steinmetz, T., Tschechne, B., Virgin, G., Klement, B., Franzem, M., Wamhoff, J., Tesch, H., Rohrberg, R., Marschner, N., 2011.

haematologica 96(s2), 0983.

Abstract

Indikation: Supportive Therapy, Supportivtherapie / Veranstaltung: EHA / Journal: Haematologica
Ferinject-NIS
2011
Treatment of cancer- and chemotherapy-associated anemia with ferric carboxymaltose in clinical practice.

Steinmetz, T., Tschechne, B., Harlin, O., Klement, B., Franzem, M., Wamhoff, J., Tech, H., Rohrberg, R., Marschner, N., 2011.

Onkologie 34 (suppl 6)(V1012), 304. doi:10.1159/000333303

Abstract

Indikation: Supportive Therapy, Supportivtherapie / Veranstaltung: DGHO / Journal: Onkologie
Ferinject-NIS
2011
REASON: A Registry for the Epidemiologic and Scientific evaluation of EGFR mutation status in newly diagnosed NSCLC patients stage IIIB/IV in Germany.

Schuette, W., Eberhardt, W., Graf von der Schulenburg, J.-M., Dietel, M., Schirmacher, P., Gutendorf, B., Thomas, M., 2011.

Amsterdam; 2011.

Indikation: Lung Cancer, Lungenkarzinom / Veranstaltung: WCLC / Journal: -
REASON
2011
LICC: L-BLP25 in patients with colorectal carcinoma after curative resection of hepatic metastases – A randomized, double-blind, placebo-controlled, multicenter, multinational, phase II trial.

Schimanski, C.C., Galle, P., Lang, H., Schoen, M., Moehler, M., 2011.

J Clin Oncol 29 (suppl)(Abstract TPS166).

Abstract

Indikation: Colorectal Cancer, Kolorektalkarzinom / Veranstaltung: ASCO / Journal: Journal of Clinical Oncology
LICC
2011
Epidemiologisches Register zur Darstellung der Behandlungsrealität und der Therapiemodalitäten beim behandlungsbedürftigen metastasierten oder lokal fortgeschrittenen Nierenzellkarzinom.

Münch A.

Sylt; 2011.

Indikation: Urogenital Tumors, Urogenitale Tumore / Veranstaltung: BDU / Journal: -
TNK
2011
Histology, metastases and palliative surgery in mRCC patients. Data from a clinical registry – RCC Registry.

Müller, L., Münch, A., Goebell, P., Hübner, A., Koska, M., Marschner, N., 2011.

Onkologie 34 (suppl 6)(P616), 182.

Abstract

Download

Indikation: Urogenital Tumors, Urogenitale Tumore / Veranstaltung: DGHO / Journal: Onkologie
TNK
2011
Real-life treatment of patients with advanced or metastatic renal cell carcinoma in German oncology and urology outpatient centers (RCC-Registry).

Müller, L., Goebell, P.J., Blumenstengel, K., Lueck, A., Koska, M., Marschner, N., 2011.

J Clin Oncol 29 (suppl 7)(Abstract 367). doi:10.1200/jco.2011.29.7_suppl.367

Abstract

Download

Indikation: Urogenital Tumors, Urogenitale Tumore / Veranstaltung: GCS (ASCO) / Journal: Journal of Clinical Oncology
TNK
2011
A preliminary report of a Phase II study of folinic acid, 5-fluorouracil, irinotecan (FOLFIRI) plus sunitinib with toxicity, efficacy, pharmacokinetics, biomarker, imaging data in patients with colorectal cancer with liver metastases as 1st line treatment.

Mross, K., Büchert, M., Fasol, U., Jaehde, U., Kanefendt, F., Strumberg, D., Arends, J., Hense, J., Moritz, B., Fischer, R., Scheulen, M.E., 2011.

Int J Clin Pharmacol Ther 49, 96–98.

Abstract

Indikation: Colorectal Cancer, Kolorektalkarzinom / Veranstaltung: - / Journal: International Journal of Clinical Pharmacology and Therapeutics
CESAR-C-II-005
2011
Networking Against Cancer.

Marschner, N., Jänicke, M., 2011.

Breast Care 6, 245–247. doi:10.1159/000329716

Abstract

Indikation: Breast Cancer, Mammakarzinom / Veranstaltung: - / Journal: Breast Care
Registerübergreifend
2011
Tumorregister Lymphatische Neoplasien – Klinisches Register zur Darstellung der Behandlungsrealität und der Therapiemodalitäten bei behandlungsbedürftigen malignen lymphatischen Systemerkrankungen der Tumorentitäten Non-Hodgkin-Lymphome, Chronische Lymphatische Leukämie und Multiples Myelom.

Knauf, W., Abenhardt, W., 2011.

Indikation: Haemoblastoma, Hämoblastosen / Veranstaltung: CLL-Studientreffen / Journal: -
TLN
2011